Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cihan Ay

Showing results (331-340 of 344) with videos related to

Pageof 35
Sort By:
The Lancet. Oncology|June 30, 2022
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19Dominique Farge, Corinne Frere, Jean M Connors, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 5, 2022
Interleukin-4 receptor alpha signaling regulates monocyte homeostasisPatrick Haider, Julia B Kral-Pointner, Manuel Salzmann, et al.
Thrombosis Journal|June 2, 2018
Correction to: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) studyAlexander T Cohen, Cihan Ay, Philippe Hainaut, et al.
Thrombosis Journal|May 3, 2018
Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) studyAlexander T Cohen, Cihan Ay, Philippe Hainaut, et al.
Journal for Immunotherapy of Cancer|December 14, 2023
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort studyDominik A Barth, Florian Moik, Sarah Steinlechner, et al.
Hemasphere|August 29, 2025
Prevention and treatment of venous thromboembolism in patients with multiple myeloma: Clinical practice guidelines on behalf of the European Myeloma NetworkGrigoris Gerotziafas, Despina Fotiou, Inger Nijhof, et al.
Thrombosis and Haemostasis|September 17, 2021
Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT StudyIsabelle Mahé, Giancarlo Agnelli, Cihan Ay, et al.
Journal of Thrombosis and Haemostasis : JTH|September 2, 2024
Biomarker-enhanced cardiovascular risk prediction in patients with cancer: a prospective cohort studySimon Kraler, Luca Liberale, Stephan Nopp, et al.
Journal of Thrombosis and Haemostasis : JTH|October 6, 2022
Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis DayNicola Potere, Stefano Barco, Isabelle Mahé, et al.
The Journal of Experimental Medicine|February 22, 2018
Correction: Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic diseaseStefan Uderhardt, Jochen A Ackermann, Tobias Fillep, et al.
Pageof 35

Showing results (331-340 of 344) with videos related to

Sort By:
Pageof 35
The Lancet. Oncology|June 30, 2022
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19Dominique Farge, Corinne Frere, Jean M Connors, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 5, 2022
Interleukin-4 receptor alpha signaling regulates monocyte homeostasisPatrick Haider, Julia B Kral-Pointner, Manuel Salzmann, et al.
Thrombosis Journal|June 2, 2018
Correction to: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) studyAlexander T Cohen, Cihan Ay, Philippe Hainaut, et al.
Thrombosis Journal|May 3, 2018
Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) studyAlexander T Cohen, Cihan Ay, Philippe Hainaut, et al.
Journal for Immunotherapy of Cancer|December 14, 2023
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort studyDominik A Barth, Florian Moik, Sarah Steinlechner, et al.
Hemasphere|August 29, 2025
Prevention and treatment of venous thromboembolism in patients with multiple myeloma: Clinical practice guidelines on behalf of the European Myeloma NetworkGrigoris Gerotziafas, Despina Fotiou, Inger Nijhof, et al.
Thrombosis and Haemostasis|September 17, 2021
Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT StudyIsabelle Mahé, Giancarlo Agnelli, Cihan Ay, et al.
Journal of Thrombosis and Haemostasis : JTH|September 2, 2024
Biomarker-enhanced cardiovascular risk prediction in patients with cancer: a prospective cohort studySimon Kraler, Luca Liberale, Stephan Nopp, et al.
Journal of Thrombosis and Haemostasis : JTH|October 6, 2022
Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis DayNicola Potere, Stefano Barco, Isabelle Mahé, et al.
The Journal of Experimental Medicine|February 22, 2018
Correction: Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic diseaseStefan Uderhardt, Jochen A Ackermann, Tobias Fillep, et al.
Pageof 35